CA2801968A1 - Procede de preparation d'acide 3,6,9-triaza-3,6,9-tris(carboxymethyl)-4-(4-ethoxybenzyl)-undecandioique cristallin et son utilisation pour la preparation de primovist® - Google Patents

Procede de preparation d'acide 3,6,9-triaza-3,6,9-tris(carboxymethyl)-4-(4-ethoxybenzyl)-undecandioique cristallin et son utilisation pour la preparation de primovist® Download PDF

Info

Publication number: CA2801968A1
Authority: CA; Canada
Prior art keywords: tris; triaza; ethoxybenzyl; carboxymethyl; undecanedioic acid
Prior art date: 2010-06-11
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

CA2801968A

Other languages

English (en)

Inventor

Johannes Platzek

Wilhelm Trentmann

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Bayer Intellectual Property GmbH

Original Assignee

Bayer Intellectual Property GmbH

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2010-06-11

Filing date

2011-06-06

Publication date

2011-12-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45098458&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2801968(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2010-06-11 Priority claimed from DE201010023890 external-priority patent/DE102010023890A1/de

2010-07-19 Priority claimed from BRPI1002466 external-priority patent/BRPI1002466A2/pt

2011-06-06 Application filed by Bayer Intellectual Property GmbH filed Critical Bayer Intellectual Property GmbH

2011-12-15 Publication of CA2801968A1 publication Critical patent/CA2801968A1/fr

Status Abandoned legal-status Critical Current

Links

AQOXEJNYXXLRQQ-UHFFFAOYSA-N 2-[[2-[bis(carboxymethyl)amino]-3-(4-ethoxyphenyl)propyl]-[2-[bis(carboxymethyl)amino]ethyl]amino]acetic acid Chemical compound CCOC1=CC=C(CC(CN(CCN(CC(O)=O)CC(O)=O)CC(O)=O)N(CC(O)=O)CC(O)=O)C=C1 AQOXEJNYXXLRQQ-UHFFFAOYSA-N 0.000 title claims abstract description 27
238000004519 manufacturing process Methods 0.000 title claims abstract description 12
239000000243 solution Substances 0.000 claims abstract description 32
229910052688 Gadolinium Inorganic materials 0.000 claims abstract description 13
UIWYJDYFSGRHKR-UHFFFAOYSA-N gadolinium atom Chemical compound [Gd] UIWYJDYFSGRHKR-UHFFFAOYSA-N 0.000 claims abstract description 13
150000008044 alkali metal hydroxides Chemical class 0.000 claims abstract description 6
JCTJIOBGZBNJPQ-UHFFFAOYSA-N tert-butyl 2-[[2-[bis[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]amino]-3-(4-ethoxyphenyl)propyl]-[2-[bis[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]amino]ethyl]amino]acetate Chemical compound CCOC1=CC=C(CC(CN(CCN(CC(=O)OC(C)(C)C)CC(=O)OC(C)(C)C)CC(=O)OC(C)(C)C)N(CC(=O)OC(C)(C)C)CC(=O)OC(C)(C)C)C=C1 JCTJIOBGZBNJPQ-UHFFFAOYSA-N 0.000 claims abstract description 5
PCZHWPSNPWAQNF-LMOVPXPDSA-K 2-[[(2s)-2-[bis(carboxylatomethyl)amino]-3-(4-ethoxyphenyl)propyl]-[2-[bis(carboxylatomethyl)amino]ethyl]amino]acetate;gadolinium(3+);hydron Chemical compound [Gd+3].CCOC1=CC=C(C[C@@H](CN(CCN(CC(O)=O)CC([O-])=O)CC([O-])=O)N(CC(O)=O)CC([O-])=O)C=C1 PCZHWPSNPWAQNF-LMOVPXPDSA-K 0.000 claims abstract description 4
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 19
238000000034 method Methods 0.000 claims description 16
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 8
239000000203 mixture Substances 0.000 claims description 8
239000011541 reaction mixture Substances 0.000 claims description 7
239000013078 crystal Substances 0.000 claims description 5
238000009472 formulation Methods 0.000 claims description 5
238000009835 boiling Methods 0.000 claims description 3
238000001816 cooling Methods 0.000 claims description 3
150000007522 mineralic acids Chemical class 0.000 claims description 3
239000002244 precipitate Substances 0.000 claims description 3
LWBHHRRTOZQPDM-UHFFFAOYSA-N undecanedioic acid Chemical compound OC(=O)CCCCCCCCCC(O)=O LWBHHRRTOZQPDM-UHFFFAOYSA-N 0.000 abstract description 6
239000007983 Tris buffer Substances 0.000 abstract description 4
230000007062 hydrolysis Effects 0.000 abstract description 2
238000006460 hydrolysis reaction Methods 0.000 abstract description 2
WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 12
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
SLYTULCOCGSBBJ-FCQHKQNSSA-I disodium;2-[[(2s)-2-[bis(carboxylatomethyl)amino]-3-(4-ethoxyphenyl)propyl]-[2-[bis(carboxylatomethyl)amino]ethyl]amino]acetate;gadolinium(3+) Chemical compound [Na+].[Na+].[Gd+3].CCOC1=CC=C(C[C@@H](CN(CCN(CC([O-])=O)CC([O-])=O)CC([O-])=O)N(CC([O-])=O)CC([O-])=O)C=C1 SLYTULCOCGSBBJ-FCQHKQNSSA-I 0.000 description 7
239000003446 ligand Substances 0.000 description 7
239000000126 substance Substances 0.000 description 6
QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 5
238000004587 chromatography analysis Methods 0.000 description 5
CMIHHWBVHJVIGI-UHFFFAOYSA-N gadolinium(iii) oxide Chemical compound [O-2].[O-2].[O-2].[Gd+3].[Gd+3] CMIHHWBVHJVIGI-UHFFFAOYSA-N 0.000 description 5
238000002347 injection Methods 0.000 description 5
239000007924 injection Substances 0.000 description 5
239000001117 sulphuric acid Substances 0.000 description 5
235000011149 sulphuric acid Nutrition 0.000 description 5
230000015572 biosynthetic process Effects 0.000 description 4
238000002425 crystallisation Methods 0.000 description 4
230000008025 crystallization Effects 0.000 description 4
229940075613 gadolinium oxide Drugs 0.000 description 4
229910001938 gadolinium oxide Inorganic materials 0.000 description 4
238000003786 synthesis reaction Methods 0.000 description 4
QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical class [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 3
239000002872 contrast media Substances 0.000 description 3
150000002148 esters Chemical class 0.000 description 3
238000004108 freeze drying Methods 0.000 description 3
238000010438 heat treatment Methods 0.000 description 3
238000004128 high performance liquid chromatography Methods 0.000 description 3
239000000047 product Substances 0.000 description 3
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
238000004458 analytical method Methods 0.000 description 2
239000000872 buffer Substances 0.000 description 2
239000011575 calcium Substances 0.000 description 2
239000013522 chelant Substances 0.000 description 2
239000002738 chelating agent Substances 0.000 description 2
238000011097 chromatography purification Methods 0.000 description 2
239000008139 complexing agent Substances 0.000 description 2
SHFJWMWCIHQNCP-UHFFFAOYSA-M hydron;tetrabutylazanium;sulfate Chemical compound OS([O-])(=O)=O.CCCC[N+](CCCC)(CCCC)CCCC SHFJWMWCIHQNCP-UHFFFAOYSA-M 0.000 description 2
150000002500 ions Chemical class 0.000 description 2
239000002405 nuclear magnetic resonance imaging agent Substances 0.000 description 2
238000013379 physicochemical characterization Methods 0.000 description 2
BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
239000002904 solvent Substances 0.000 description 2
125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
238000010998 test method Methods 0.000 description 2
239000012085 test solution Substances 0.000 description 2
238000004809 thin layer chromatography Methods 0.000 description 2
238000003325 tomography Methods 0.000 description 2
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
230000005526 G1 to G0 transition Effects 0.000 description 1
KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical class [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
229910000831 Steel Inorganic materials 0.000 description 1
239000008186 active pharmaceutical agent Substances 0.000 description 1
150000001669 calcium Chemical class 0.000 description 1
229910052791 calcium Inorganic materials 0.000 description 1
229910000019 calcium carbonate Inorganic materials 0.000 description 1
238000006243 chemical reaction Methods 0.000 description 1
239000003153 chemical reaction reagent Substances 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
238000011210 chromatographic step Methods 0.000 description 1
239000013065 commercial product Substances 0.000 description 1
238000000354 decomposition reaction Methods 0.000 description 1
239000007857 degradation product Substances 0.000 description 1
238000011033 desalting Methods 0.000 description 1
238000003745 diagnosis Methods 0.000 description 1
SLYTULCOCGSBBJ-UHFFFAOYSA-I disodium;2-[[2-[bis(carboxylatomethyl)amino]-3-(4-ethoxyphenyl)propyl]-[2-[bis(carboxylatomethyl)amino]ethyl]amino]acetate;gadolinium(3+) Chemical compound [Na+].[Na+].[Gd+3].CCOC1=CC=C(CC(CN(CCN(CC([O-])=O)CC([O-])=O)CC([O-])=O)N(CC([O-])=O)CC([O-])=O)C=C1 SLYTULCOCGSBBJ-UHFFFAOYSA-I 0.000 description 1
229940088679 drug related substance Drugs 0.000 description 1
238000001035 drying Methods 0.000 description 1
238000001704 evaporation Methods 0.000 description 1
230000008020 evaporation Effects 0.000 description 1
229960001547 gadoxetic acid Drugs 0.000 description 1
239000007789 gas Substances 0.000 description 1
230000010354 integration Effects 0.000 description 1
238000001990 intravenous administration Methods 0.000 description 1
238000005342 ion exchange Methods 0.000 description 1
238000002955 isolation Methods 0.000 description 1
229910052747 lanthanoid Inorganic materials 0.000 description 1
150000002602 lanthanoids Chemical class 0.000 description 1
239000000463 material Substances 0.000 description 1
238000002844 melting Methods 0.000 description 1
230000008018 melting Effects 0.000 description 1
239000012528 membrane Substances 0.000 description 1
229910052757 nitrogen Inorganic materials 0.000 description 1
230000020477 pH reduction Effects 0.000 description 1
238000004806 packaging method and process Methods 0.000 description 1
238000001959 radiotherapy Methods 0.000 description 1
238000001953 recrystallisation Methods 0.000 description 1
238000010992 reflux Methods 0.000 description 1
QEVHRUUCFGRFIF-MDEJGZGSSA-N reserpine Chemical compound O([C@H]1[C@@H]([C@H]([C@H]2C[C@@H]3C4=C(C5=CC=C(OC)C=C5N4)CCN3C[C@H]2C1)C(=O)OC)OC)C(=O)C1=CC(OC)=C(OC)C(OC)=C1 QEVHRUUCFGRFIF-MDEJGZGSSA-N 0.000 description 1
102220079670 rs759826252 Human genes 0.000 description 1
238000007127 saponification reaction Methods 0.000 description 1
239000007787 solid Substances 0.000 description 1
238000007655 standard test method Methods 0.000 description 1
239000010959 steel Substances 0.000 description 1
239000000725 suspension Substances 0.000 description 1
238000011003 system suitability test Methods 0.000 description 1
238000011282 treatment Methods 0.000 description 1
229960000281 trometamol Drugs 0.000 description 1
238000005292 vacuum distillation Methods 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/14—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
- C07C227/18—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/38—Separation; Purification; Stabilisation; Use of additives
- C07C227/40—Separation; Purification
- C07C227/42—Crystallisation
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
- C07C229/10—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
- C07C229/16—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of hydrocarbon radicals substituted by amino or carboxyl groups, e.g. ethylenediamine-tetra-acetic acid, iminodiacetic acids
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/26—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one amino group bound to the carbon skeleton, e.g. lysine
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
- C07C229/36—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings with at least one amino group and one carboxyl group bound to the same carbon atom of the carbon skeleton

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Crystallography & Structural Chemistry (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

CA2801968A 2010-06-11 2011-06-06 Procede de preparation d'acide 3,6,9-triaza-3,6,9-tris(carboxymethyl)-4-(4-ethoxybenzyl)-undecandioique cristallin et son utilisation pour la preparation de primovist® Abandoned CA2801968A1 (fr)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
DE102010023890.2		2010-06-11
DE201010023890 DE102010023890A1 (de)	2010-06-11	2010-06-11	Verfahren zur Herstellung kristalliner 3,6,9-Triaza-3,6,9-tris(carboxymethyl)-4-(ethoxybenzyl)-undecandinsäure und die Verwendung zur Herstellung von Primovist
BRPI1002466-2		2010-07-19
BRPI1002466 BRPI1002466A2 (pt)	2010-07-19	2010-07-19	processo para preparação de diácido 3,6,9-triaza-3,6,9-tris(carboximetil)-4-(4-etoxibenzil)-u ndecánico cristalino e seu uso para preparação de primovist«
PCT/EP2011/059243 WO2011154333A2 (fr)	2010-06-11	2011-06-06	Procédé de préparation d'acide 3,6,9-triaza-3,6,9-tris(carboxyméthyl)-4-(4-éthoxybenzyl)-undécandioïque cristallin et son utilisation pour la préparation de primovist®

Publications (1)

Publication Number	Publication Date
CA2801968A1 true CA2801968A1 (fr)	2011-12-15

Family

ID=45098458

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA2801968A Abandoned CA2801968A1 (fr)	2010-06-11	2011-06-06	Procede de preparation d'acide 3,6,9-triaza-3,6,9-tris(carboxymethyl)-4-(4-ethoxybenzyl)-undecandioique cristallin et son utilisation pour la preparation de primovist®

Country Status (24)

Country	Link
US (1)	US20130158241A1 (fr)
EP (1)	EP2580184A2 (fr)
JP (1)	JP2013531643A (fr)
KR (1)	KR20130111513A (fr)
CN (1)	CN103068790A (fr)
AU (1)	AU2011263890A1 (fr)
CA (1)	CA2801968A1 (fr)
CL (1)	CL2012003497A1 (fr)
CO (1)	CO6650345A2 (fr)
CR (1)	CR20120627A (fr)
CU (1)	CU20120168A7 (fr)
EC (1)	ECSP12012335A (fr)
GT (1)	GT201200335A (fr)
IL (1)	IL223553A0 (fr)
MA (1)	MA34304B1 (fr)
MX (1)	MX2012014490A (fr)
PE (1)	PE20130458A1 (fr)
PH (1)	PH12012502427A1 (fr)
RU (1)	RU2012157539A (fr)
SG (1)	SG186259A1 (fr)
TN (1)	TN2012000585A1 (fr)
TW (1)	TW201206876A (fr)
WO (1)	WO2011154333A2 (fr)
ZA (1)	ZA201300256B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN103420862B (zh) *	2012-05-16	2015-04-22	齐鲁制药有限公司	一种钆塞酸二钠中间体化合物的金属盐、其晶型及制备方法
CN104672099A (zh) *	2013-11-27	2015-06-03	山东富创医药科技有限公司	一种新的钆塞酸二钠中间体的制备方法
CN104130146B (zh) *	2014-07-31	2016-03-02	苏州昊帆生物科技有限公司	(4s)-3，6，9-三氮杂-3，6，9-三(羧甲基)-4-(4-乙氧基苄基)十一烷二酸的制备方法
EP3464237B1 (fr) *	2016-05-30	2023-12-20	Biophore India Pharmaceuticals Pvt. Ltd.	Nouveau procédé pour la préparation de complexe de gadolinium d'acide (4s)-4-(4-éthoxybenzyl) -3,6,9-tris (carboxylatométhyl)-3,6,9-triazaundécanedioïque disodique (gadoxate disodique)
CN109851516B (zh) *	2019-01-28	2020-10-02	湖北天舒药业有限公司	用于钆系造影剂中叔丁酯的水解方法
CN115876898B (zh) *	2021-09-27	2024-10-01	长沙创新药物工业技术研究院有限公司	一种聚乙二醇修饰剂的制备及纯度测定方法
CN115043747B (zh) *	2022-08-15	2022-11-25	康瑞鑫(天津)药物研究院有限公司	卡洛酸三钠的析晶方法及制备的卡洛酸三钠晶体

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3640708C2 (de)	1986-11-28	1995-05-18	Schering Ag	Verbesserte metallhaltige Pharmazeutika
DE3922005A1 (de)	1989-06-30	1991-01-10	Schering Ag	Derivatisierte dtpa-komplexe, diese verbindungen enthaltende pharmazeutische mittel, ihre verwendung und verfahren zu deren herstellung
SK68897A3 (en) *	1994-11-30	1998-10-07	Schering Ag	Use of chelate compounds as diagnostic agents in the x-ray examination of liver and bile ducts
DE19712012A1 (de) *	1997-03-13	1998-09-24	Schering Ag	Verfahren zur Herstellung kristalliner 3,6,9-Triaza-3,6-9-tris(carboxymethyl)-4-(4- ethoxybenzyl)-undecandisäure

2011
- 2011-06-06 SG SG2012090684A patent/SG186259A1/en unknown
- 2011-06-06 JP JP2013513641A patent/JP2013531643A/ja not_active Withdrawn
- 2011-06-06 MX MX2012014490A patent/MX2012014490A/es not_active Application Discontinuation
- 2011-06-06 WO PCT/EP2011/059243 patent/WO2011154333A2/fr not_active Ceased
- 2011-06-06 RU RU2012157539/04A patent/RU2012157539A/ru not_active Application Discontinuation
- 2011-06-06 CN CN2011800388543A patent/CN103068790A/zh active Pending
- 2011-06-06 KR KR1020137000174A patent/KR20130111513A/ko not_active Withdrawn
- 2011-06-06 PE PE2012002300A patent/PE20130458A1/es not_active Application Discontinuation
- 2011-06-06 EP EP11724612.4A patent/EP2580184A2/fr not_active Withdrawn
- 2011-06-06 AU AU2011263890A patent/AU2011263890A1/en not_active Abandoned
- 2011-06-06 PH PH1/2012/502427A patent/PH12012502427A1/en unknown
- 2011-06-06 CA CA2801968A patent/CA2801968A1/fr not_active Abandoned
- 2011-06-06 US US13/703,579 patent/US20130158241A1/en not_active Abandoned
- 2011-06-06 MA MA35444A patent/MA34304B1/fr unknown
- 2011-06-10 TW TW100120431A patent/TW201206876A/zh unknown
2012
- 2012-12-10 TN TNP2012000585A patent/TN2012000585A1/en unknown
- 2012-12-11 EC ECSP12012335 patent/ECSP12012335A/es unknown
- 2012-12-11 CO CO12224294A patent/CO6650345A2/es unknown
- 2012-12-11 CR CR20120627A patent/CR20120627A/es unknown
- 2012-12-11 IL IL223553A patent/IL223553A0/en unknown
- 2012-12-11 GT GT201200335A patent/GT201200335A/es unknown
- 2012-12-11 CL CL2012003497A patent/CL2012003497A1/es unknown
- 2012-12-11 CU CU2012000168A patent/CU20120168A7/es unknown
2013
- 2013-01-10 ZA ZA2013/00256A patent/ZA201300256B/en unknown

Also Published As

Publication number	Publication date
US20130158241A1 (en)	2013-06-20
SG186259A1 (en)	2013-01-30
JP2013531643A (ja)	2013-08-08
TN2012000585A1 (en)	2014-04-01
PH12012502427A1 (en)	2013-02-18
AU2011263890A1 (en)	2013-01-24
ECSP12012335A (es)	2012-12-28
TW201206876A (en)	2012-02-16
CN103068790A (zh)	2013-04-24
WO2011154333A2 (fr)	2011-12-15
ZA201300256B (en)	2014-06-25
KR20130111513A (ko)	2013-10-10
RU2012157539A (ru)	2014-07-20
PE20130458A1 (es)	2013-04-11
EP2580184A2 (fr)	2013-04-17
CU20120168A7 (es)	2013-04-19
WO2011154333A3 (fr)	2012-02-16
MA34304B1 (fr)	2013-06-01
IL223553A0 (en)	2013-03-05
GT201200335A (es)	2014-03-25
MX2012014490A (es)	2013-02-07
CR20120627A (es)	2013-03-13
CL2012003497A1 (es)	2013-03-22
CO6650345A2 (es)	2013-04-15

Legal Events

Date	Code	Title	Description
2016-07-20	FZDE	Discontinued	Effective date: 20160608

Publication	Publication Date	Title
CA2726599C (fr)	2017-07-25	Procede de preparation de sel a partir de treprostinil
JP7444914B2 (ja)	2024-03-06	カルコブトロールの変態ａの結晶形態を製造する方法
AU2011263890A1 (en)	2013-01-24	Process for preparing crystalline 3,6,9-triaza-3,6,9-tris(carboxymethyl)-4-(4-ethoxybenzyl)undecanedioic acid and use for production of primovist®
CN119039292A (zh)	2024-11-29	基于带有钆的pcta的造影剂
US20190284219A1 (en)	2019-09-19	Hydrated and anhydrous polymorphs of 2'-o-fucosyllactose and their production methods
KR20190079682A (ko)	2019-07-05	고순도 가도부트롤의 제조
TWI302531B (en)	2008-11-01	Lithium complexes of n-(1-hydroxymethyl-2,3-dihydroxypropyl)-1,4,7-triscarboxymethyl-1,4,7-10-tetraazacyclododecane, their production and use
JP2023062038A (ja)	2023-05-02	ガドブトロールの製造方法
ITMI981583A1 (it)	2000-01-10	Processo per la preparazione dell'acido 4 -carbossi-5,8,11-tris (carbossimetil)-1-fenil-2-oxa-5,8,11-triazatridecan-13-oico
HK1184437A (en)	2014-01-24	Process for preparing crystalline 3,6,9-triaza-3,6,9-tris(carboxymethyl)-4-(4-ethoxybenzyl)undecanedioic acid and use for production of primovist®
CN103420862A (zh)	2013-12-04	一种钆塞酸二钠中间体化合物的金属盐、其晶型及制备方法
JP2021138695A (ja)	2021-09-16	カルコブトロールの製造方法
BRPI1002466A2 (pt)	2012-05-15	processo para preparação de diácido 3,6,9-triaza-3,6,9-tris(carboximetil)-4-(4-etoxibenzil)-u ndecánico cristalino e seu uso para preparação de primovist«
CN101153013B (zh)	2011-05-11	一种dl-酪氨酸-15n的制备方法
WO2026017628A1 (fr)	2026-01-22	Procédé de purification de 2-amino-1,3-propanediol (sérinol)
US20120041022A1 (en)	2012-02-16	Process for preparing enantiomerically enriched alkaloids
CN103772307A (zh)	2014-05-07	一种DOTA·2HCl的制备方法